President Trump on Thursday announced a deal to drastically lower the price of weight loss drugs for some Americans.

"Today, I'm thrilled to announce that the two world's largest pharmaceutical manufacturers, Eli Lilly and Novo Nordisk, have agreed to offer their most popular GLP-1 weight loss drug — I call it the fat drug, remember — at drastic discounts," the president announced in the Oval Office.

Under the deal, Eli Lilly, the maker of Zepbound, and Novo Nordisk, the company behind Ozempic and Wegovy, have agreed to lower the price of their weight loss drugs for eligible patients on Medicare, Medicaid and for eligible users of the planned "TrumpRx" pharmaceutical website.

The price per month for most eligible people will be $245 to $350 a month on average, administration offici

See Full Page